Obstructive jaundice secondary to choledocholithiasis not in cholangitis Anatomy Physiology Gradings Tabels Guidelines Pathophysio Mangaement Treatment In short evrything i should know regarding this topic

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

choledocholithiasis management guidelines

Searching Images

biliary anatomy common bile duct diagram

An anatomical diagram illustrating the human biliary tree and its relationship to adjacent hepatobiliary structures. The diagram depicts the biliary drainage system (colored green) beginning with the common bile duct, which receives the cystic duct from the gallbladder. Superior to this confluence is the common hepatic duct, which bifurcates into the right and left hepatic ducts. The right hepatic duct further branches into the right anterior (supplying segments 5 and 8) and right posterior (supplying segments 6 and 7) hepatic ducts. The left hepatic duct provides drainage for segments 1, 2, 3, and 4. Vascular landmarks are also shown: the portal vein (colored blue) is situated posterior to the common bile duct, and the right hepatic artery (colored red) is seen crossing posterior to the common hepatic duct. The gallbladder is positioned alongside the duodenum, with its cystic duct connecting to the main biliary channel. This diagram serves as a pedagogical tool for understanding segmental liver anatomy and surgical landmarks in the porta hepatis.

An anatomical diagram illustrating the human biliary tree and its relationship to adjacent hepatobiliary structures. The diagram depicts the biliary drainage system (colored green) beginning with the common bile duct, which receives the cystic duct from the gallbladder. Superior to this confluence is the common hepatic duct, which bifurcates into the right and left hepatic ducts. The right hepatic duct further branches into the right anterior (supplying segments 5 and 8) and right posterior (supplying segments 6 and 7) hepatic ducts. The left hepatic duct provides drainage for segments 1, 2, 3, and 4. Vascular landmarks are also shown: the portal vein (colored blue) is situated posterior to the common bile duct, and the right hepatic artery (colored red) is seen crossing posterior to the common hepatic duct. The gallbladder is positioned alongside the duodenum, with its cystic duct connecting to the main biliary channel. This diagram serves as a pedagogical tool for understanding segmental liver anatomy and surgical landmarks in the porta hepatis.

A split-view image consisting of a clinical photograph and a corresponding anatomical illustration demonstrating the placement of a biliary stent within the common bile duct (CBD). Left: A grayscale laparoscopic image shows a surgical field within the hepatic hilum. A cylindrical, tubular biliary stent is visible, positioned antegrade within the bile duct to maintain patency. Laparoscopic instruments, including a grasper or probe, are visible in the foreground, indicating an active minimally invasive procedure. The surrounding tissue shows signs of surgical dissection, likely in the context of Mirizzi syndrome management. Right: A detailed medical illustration provides a schematic view of the biliary anatomy. It depicts the CBD containing the stent, the confluence of the hepatic ducts, and the relationship of the biliary tree to the duodenum and pancreas. The diagram highlights the intraluminal positioning of the stent and the anatomical landmarks essential for identifying cholecystobiliary fistulas. This visual pair serves as a guide for surgical trainees in understanding laparoscopic biliary decompression and reconstruction techniques.

A split-view image consisting of a clinical photograph and a corresponding anatomical illustration demonstrating the placement of a biliary stent within the common bile duct (CBD). Left: A grayscale laparoscopic image shows a surgical field within the hepatic hilum. A cylindrical, tubular biliary stent is visible, positioned antegrade within the bile duct to maintain patency. Laparoscopic instruments, including a grasper or probe, are visible in the foreground, indicating an active minimally invasive procedure. The surrounding tissue shows signs of surgical dissection, likely in the context of Mirizzi syndrome management. Right: A detailed medical illustration provides a schematic view of the biliary anatomy. It depicts the CBD containing the stent, the confluence of the hepatic ducts, and the relationship of the biliary tree to the duodenum and pancreas. The diagram highlights the intraluminal positioning of the stent and the anatomical landmarks essential for identifying cholecystobiliary fistulas. This visual pair serves as a guide for surgical trainees in understanding laparoscopic biliary decompression and reconstruction techniques.

This composite educational graphic details hepatobiliary anatomy and the interventional management of biliary strictures. Panel A is an anatomical diagram of the liver and biliary tree, labeling the left and right hepatic ducts, common hepatic duct (CHD), cystic duct, and common bile duct (CBD). Panel B is a fluoroscopic image from an endoscopic retrograde cholangiopancreatography (ERCP) demonstrating a high-grade stricture in the common hepatic duct (indicated by an arrow). A guide wire and stent catheter are seen traversing the narrowed segment to maintain access. Panel C shows the follow-up fluoroscopy after the deployment of a self-expanding metal (SEM) stent (highlighted by a green circle). The SEM stent has successfully dilated the CHD stricture, restoring ductal patency to alleviate cholestasis. The images highlight the clinical progression from diagnostic identification of extrahepatic bile duct obstruction to therapeutic resolution using interventional gastroenterology techniques.

This composite educational graphic details hepatobiliary anatomy and the interventional management of biliary strictures. Panel A is an anatomical diagram of the liver and biliary tree, labeling the left and right hepatic ducts, common hepatic duct (CHD), cystic duct, and common bile duct (CBD). Panel B is a fluoroscopic image from an endoscopic retrograde cholangiopancreatography (ERCP) demonstrating a high-grade stricture in the common hepatic duct (indicated by an arrow). A guide wire and stent catheter are seen traversing the narrowed segment to maintain access. Panel C shows the follow-up fluoroscopy after the deployment of a self-expanding metal (SEM) stent (highlighted by a green circle). The SEM stent has successfully dilated the CHD stricture, restoring ductal patency to alleviate cholestasis. The images highlight the clinical progression from diagnostic identification of extrahepatic bile duct obstruction to therapeutic resolution using interventional gastroenterology techniques.

This composite educational image includes contrast-enhanced computed tomography (CT) scans (a-c) and a schematic diagram (d) illustrating an intrabiliary mass. The axial CT sections demonstrate significant intrahepatic bile duct dilatation in the right lobe, specifically in the posterior segment extending toward the hepatic confluence. A single arrow in panels a and b indicates the dilated ductal system, while multiple arrows in panel c highlight a low-density intraluminal mass causing the obstruction. The schematic diagram (d) maps the biliary anatomy, showing the convergence of the anterior right hepatic duct (Bant), posterior right hepatic duct (Bpost), and left-sided ducts from segments B2, B3, and B4. The diagram identifies the tumor location ('mass') at the confluence involving the common hepatic duct. A percutaneous transhepatic biliary drainage (PTBD) catheter is depicted in situ, and the spatial relationship to the gallbladder and common bile duct is shown. This visual set is used to teach diagnostic recognition of biliary tumors, such as intrahepatic cholangiocarcinoma or metastatic intrabiliary growth, and their radiographic presentation.

This composite educational image includes contrast-enhanced computed tomography (CT) scans (a-c) and a schematic diagram (d) illustrating an intrabiliary mass. The axial CT sections demonstrate significant intrahepatic bile duct dilatation in the right lobe, specifically in the posterior segment extending toward the hepatic confluence. A single arrow in panels a and b indicates the dilated ductal system, while multiple arrows in panel c highlight a low-density intraluminal mass causing the obstruction. The schematic diagram (d) maps the biliary anatomy, showing the convergence of the anterior right hepatic duct (Bant), posterior right hepatic duct (Bpost), and left-sided ducts from segments B2, B3, and B4. The diagram identifies the tumor location ('mass') at the confluence involving the common hepatic duct. A percutaneous transhepatic biliary drainage (PTBD) catheter is depicted in situ, and the spatial relationship to the gallbladder and common bile duct is shown. This visual set is used to teach diagnostic recognition of biliary tumors, such as intrahepatic cholangiocarcinoma or metastatic intrabiliary growth, and their radiographic presentation.

Finding Sources
Finding Sources
Finding Sources
Searching PubMed

choledocholithiasis ERCP treatment

Searching Images

choledocholithiasis ERCP stone extraction bile duct

This endoscopic clinical photograph captures a biliary stone extraction procedure during an Endoscopic Retrograde Cholangiopancreatography (ERCP). The central focus is on several large choledocholiths (bile duct stones) being retrieved from the common bile duct. The stones exhibit a characteristic dark green to brownish-black pigmentation, suggestive of bile staining, with a notably coarse and irregular surface texture. Reflection of the light source creates bright specular highlights on the moist surface of the calculi. A white, flexible, cylindrical balloon-tipped catheter with dark orientation markings is visible in the foreground, utilized to sweep and mobilize the stones into the duodenum. The surrounding duodenal mucosa and ampullary region are partially visible, appearing erythematous and typical for the clinical context of biliary obstruction and intervention. This image serves as a visual demonstration of therapeutic endoscopy in the management of choledocholithiasis and obstructive jaundice.

This endoscopic clinical photograph captures a biliary stone extraction procedure during an Endoscopic Retrograde Cholangiopancreatography (ERCP). The central focus is on several large choledocholiths (bile duct stones) being retrieved from the common bile duct. The stones exhibit a characteristic dark green to brownish-black pigmentation, suggestive of bile staining, with a notably coarse and irregular surface texture. Reflection of the light source creates bright specular highlights on the moist surface of the calculi. A white, flexible, cylindrical balloon-tipped catheter with dark orientation markings is visible in the foreground, utilized to sweep and mobilize the stones into the duodenum. The surrounding duodenal mucosa and ampullary region are partially visible, appearing erythematous and typical for the clinical context of biliary obstruction and intervention. This image serves as a visual demonstration of therapeutic endoscopy in the management of choledocholithiasis and obstructive jaundice.

This endoscopic clinical photograph demonstrates a biliary stone extraction procedure during an Endoscopic Retrograde Cholangiopancreatography (ERCP). The primary visual focus is a large, irregularly shaped choledocholith (biliary stone) being retrieved from the common bile duct. The stone exhibits a predominantly yellow-brown, ochre-like coloration with a rough, granular surface texture, characteristic of a mixed cholesterol and pigment stone. A mechanical retrieval device, specifically a wire-guided stone extraction basket, is visible with its thin metal wires tightly encompassing the stone to secure it for passage through the papilla into the duodenal lumen. The background shows the pinkish, mucosal lining of the gastrointestinal tract and the transparent distal attachment (cap) of the endoscope used for better visualization and tissue retraction. This image illustrates the therapeutic management of choledocholithiasis and the use of specialized endoscopic accessories in hepatobiliary intervention.

This endoscopic clinical photograph demonstrates a biliary stone extraction procedure during an Endoscopic Retrograde Cholangiopancreatography (ERCP). The primary visual focus is a large, irregularly shaped choledocholith (biliary stone) being retrieved from the common bile duct. The stone exhibits a predominantly yellow-brown, ochre-like coloration with a rough, granular surface texture, characteristic of a mixed cholesterol and pigment stone. A mechanical retrieval device, specifically a wire-guided stone extraction basket, is visible with its thin metal wires tightly encompassing the stone to secure it for passage through the papilla into the duodenal lumen. The background shows the pinkish, mucosal lining of the gastrointestinal tract and the transparent distal attachment (cap) of the endoscope used for better visualization and tissue retraction. This image illustrates the therapeutic management of choledocholithiasis and the use of specialized endoscopic accessories in hepatobiliary intervention.

A multi-modal image series documenting the diagnosis and management of choledocholithiasis via Endoscopic Retrograde Cholangiopancreatography (ERCP). Image (a) is a cross-sectional CT scan showing a hyperdense, 5mm stone in the distal common bile duct (CBD). Images (b, d, f) provide endoscopic views showing biliary cannulation with a guidewire, endoscopic sphincterotomy of the papilla, and mechanical stone extraction using a Dormia basket. Images (c, e, g) are fluoroscopic cholangiograms. (c) demonstrates a radiolucent filling defect in the distal CBD representing the stone. (e) shows the ductal anatomy post-sphincterotomy, and (g) confirms successful stone clearance with a balloon-occlusion cholangiogram showing no residual filling defects. The series illustrates the standard interventional sequence: identification, cannulation, sphincterotomy, extraction, and final clearance verification.

A multi-modal image series documenting the diagnosis and management of choledocholithiasis via Endoscopic Retrograde Cholangiopancreatography (ERCP). Image (a) is a cross-sectional CT scan showing a hyperdense, 5mm stone in the distal common bile duct (CBD). Images (b, d, f) provide endoscopic views showing biliary cannulation with a guidewire, endoscopic sphincterotomy of the papilla, and mechanical stone extraction using a Dormia basket. Images (c, e, g) are fluoroscopic cholangiograms. (c) demonstrates a radiolucent filling defect in the distal CBD representing the stone. (e) shows the ductal anatomy post-sphincterotomy, and (g) confirms successful stone clearance with a balloon-occlusion cholangiogram showing no residual filling defects. The series illustrates the standard interventional sequence: identification, cannulation, sphincterotomy, extraction, and final clearance verification.

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File

Obstructive Jaundice Secondary to Choledocholithiasis (Non-Cholangitis)

A Complete Reference Guide


1. ANATOMY OF THE BILIARY SYSTEM

Biliary tree anatomy diagram showing CBD, hepatic ducts, gallbladder, portal vein and hepatic artery

Extrahepatic Biliary Tree

StructureDetail
Right hepatic ductDrains segments 5, 6, 7, 8 (right anterior + right posterior ducts)
Left hepatic ductDrains segments 1, 2, 3, 4
Common hepatic duct (CHD)Union of right + left hepatic ducts at porta hepatis
Cystic ductConnects gallbladder to CHD; contains spiral valves of Heister
Common bile duct (CBD)CHD + cystic duct; ~8 cm long, 6 mm normal diameter
Ampulla of VaterCBD + pancreatic duct join, drain through this into 2nd part of duodenum
Sphincter of OddiSmooth muscle complex controlling bile + pancreatic secretion flow

CBD Segments (4 parts)

  1. Supraduodenal - in free edge of lesser omentum (hepatoduodenal ligament), anterior to portal vein, right of hepatic artery
  2. Retroduodenal - passes posterior to 1st part of duodenum
  3. Infraduodenal (intrapancreatic) - runs through or behind head of pancreas - most common site for stone impaction
  4. Intraduodenal (intramural) - pierces wall of duodenum, joins pancreatic duct

Key Relations in Hepatoduodenal Ligament (from left to right):

  • Anterior right: CBD
  • Anterior left: Hepatic artery proper
  • Posterior: Portal vein
(Gray's Anatomy for Students)

2. PHYSIOLOGY OF BILIRUBIN & OBSTRUCTIVE JAUNDICE

Normal Bilirubin Metabolism

Hemoglobin breakdown (RES)
        ↓
Unconjugated bilirubin (fat-soluble, bound to albumin)
        ↓ [Liver - UDP-glucuronosyltransferase]
Conjugated bilirubin (water-soluble)
        ↓ [Secreted into bile canaliculi]
Bile → duodenum → urobilinogen → stercobilin (stool color)
                      ↓ (80% reabsorbed enterohepatic circulation)
                   Urobilinogen → urine (urobilinogen)

What Happens in CBD Obstruction

When a stone obstructs the CBD:
  • Conjugated bilirubin cannot be excreted into the duodenum
  • Bile canaliculi become congested and rupture
  • Conjugated bilirubin regurgitates into hepatic veins and lymphatics
  • Result: conjugated (direct) hyperbilirubinemia in the blood
  • Bilirubin appears in urine (choluria - dark urine)
  • No bilirubin reaches the bowel → no urobilinogen → pale/clay-colored stools
  • Secondary: bile salt accumulation → pruritus
  • Hepatic backup → hepatomegaly, elevation of ALP and GGT (predominantly cholestatic pattern)

Laboratory Pattern in Obstructive Jaundice

ParameterResult
Serum bilirubin↑↑ Direct (conjugated) predominantly
Urine bilirubinPresent (choluria)
Urine urobilinogenAbsent
Fecal urobilinogenTrace to absent (pale stools)
Alkaline phosphatase (ALP)↑↑↑ (markedly elevated)
GGT↑↑↑ (most sensitive and specific)
AST / ALTMildly ↑ (can spike early with acute obstruction)
PT / INR↑ (decreased vitamin K absorption due to absent bile)
Serum albumin↓ (prolonged obstruction)
(Harper's Illustrated Biochemistry 32nd ed; Guyton & Hall Textbook of Medical Physiology)

3. CHOLEDOCHOLITHIASIS - DEFINITION & CLASSIFICATION

Choledocholithiasis = presence of stones in the extrahepatic biliary tree (CBD and hepatic ducts).

Types of CBD Stones

Primary CBD StonesSecondary CBD Stones
OriginWithin the bile duct itselfFrom gallbladder, migrated into CBD
CompositionBrown pigment (calcium bilirubinate)Cholesterol (majority)
AssociationsBile stasis, benign biliary strictures, bile duct cysts, sphincter of Oddi dysfunction, post-cholecystectomyCholelithiasis (gallstones) - most common type
FrequencyLess commonMost common - 10-15% of patients with symptomatic gallstones
(Mulholland & Greenfield's Surgery 7e)

4. PATHOPHYSIOLOGY OF OBSTRUCTIVE JAUNDICE

Sequence of Events After CBD Stone Impaction

Stone impacts CBD (most often at intrapancreatic / distal segment)
        ↓
Mechanical obstruction of bile flow
        ↓
Biliary back-pressure increases
        ↓
Intrahepatic bile duct dilation → Liver congestion
        ↓
Bile canaliculi rupture → Conjugated bilirubin regurgitates into blood
        ↓
Conjugated hyperbilirubinemia + Choluria + Acholic stools + Pruritus
        ↓
Continued obstruction → Hepatocyte damage
        ↓
Impaired vitamin K absorption (fat-soluble) → Coagulopathy
        ↓
Gut barrier failure + Systemic endotoxemia → Risk of Renal failure (hepatorenal)
        ↓
Bacterial translocation → Risk of Cholangitis (if infection supervenes)

Systemic Effects of Prolonged Biliary Obstruction

SystemEffect
RenalHepatorenal syndrome - renal tubular bilirubin deposition, endotoxemia-mediated vasoconstriction
CoagulationPT prolongation due to reduced fat-soluble vitamin K absorption
ImmuneEndotoxemia (infected bile 95%+), reduced Kupffer cell function
NutritionalHypoalbuminemia, fat malabsorption
Wound healingImpaired (especially in malignant obstruction)
Salt-waterFluid retention, hyponatremia tendency
(Pye's Surgical Handicraft 22e)

5. CLINICAL PRESENTATION

Spectrum of Presentation

SeverityFeatures
AsymptomaticIncidental finding on imaging
Biliary colicRUQ pain (most common presentation), intermittent with stone passage
Obstructive jaundiceJaundice + dark urine + pale stools + pruritus ± RUQ pain
Gallstone pancreatitisEpigastric pain radiating to back, raised amylase/lipase
Charcot's TriadFever + Jaundice + RUQ pain → Cholangitis (not our topic here)
Reynolds PentadCharcot's triad + Hypotension + Altered mental status → Severe cholangitis
Key: In non-cholangitis choledocholithiasis, the patient is afebrile with no systemic sepsis signs - just jaundice ± biliary colic.
  • 5-20% of patients with symptomatic gallstones have CBD stones
  • 10-20% of patients presenting with cholecystitis will also have choledocholithiasis
  • CBD stones can pass spontaneously (~30% of low-risk patients)
  • Intermittent obstruction causes fluctuating LFTs and bilirubin levels
(Symptom to Diagnosis 4e; Fischer's Mastery of Surgery 8e)

6. DIAGNOSIS

Step 1 - Biochemical Tests

  • LFTs have strong negative predictive value (97%) but only 15-50% positive predictive value
  • GGT is the most sensitive and specific marker
  • Rising ALP disproportionate to transaminases = obstructive pattern

Step 2 - Imaging Modalities

ModalitySensitivity for CBD StonesNotes
Transabdominal USS22-60% (poor)Operator-dependent; identifies dilated CBD (>6mm) and gallstones well
CT abdomenLowBetter for complications; stones may be isodense
MRCP81-100% sensitivity, 92-100% specificityGold standard noninvasive imaging; may miss stones <5mm
EUS (Endoscopic USS)>90%Best for intermediate-risk patients; if negative, avoids ERCP
IOC (Intraoperative cholangiogram)HighPerformed at time of laparoscopic cholecystectomy
ERCPNear 100%Gold standard diagnostic + therapeutic; reserved for high risk
(Mulholland & Greenfield's Surgery 7e)

7. RISK STRATIFICATION - ASGE GRADING

ASGE Predictors of Choledocholithiasis (Table 61.5)

Predictor CategorySpecific Predictors
Very StrongCBD stone seen on transabdominal USS, Ascending cholangitis, Bilirubin >4 mg/dL
StrongDilated CBD (>6 mm) on USS, Bilirubin elevated (1.8-4 mg/dL)
ModerateAbnormal liver biochemical tests (other than bilirubin), Age >55, Clinical gallstone pancreatitis

Risk Classification

Risk LevelCriteriaProbability of CBD StonesAction
HIGHAny single Very Strong predictor present>50%Proceed directly to ERCP
LOWNo predictors at all<10%Proceed to Laparoscopic cholecystectomy (± IOC)
INTERMEDIATEAll other patients (Strong or Moderate predictors)10-50%EUS or MRCP first, then ERCP if positive
(American Society for Gastrointestinal Endoscopy guidelines; Mulholland & Greenfield's Surgery 7e)

8. MANAGEMENT ALGORITHM

Suspected Choledocholithiasis (obstructive jaundice, no cholangitis)
                    ↓
         ASGE Risk Stratification
        /           |            \
    HIGH          INTERMEDIATE    LOW
      ↓               ↓            ↓
    ERCP         EUS or MRCP    Lap Chole
  (diagnostic +      ↓          ± IOC
  therapeutic)   Stone found?       ↓
      ↓          Yes → ERCP     No stone
  Stone cleared  No → Lap Chole  confirmed
      ↓
 Lap Cholecystectomy
 (same admission or
  within 2 weeks)

9. TREATMENT OPTIONS

A. Endoscopic Approach (ERCP) - FIRST LINE

ERCP is the primary therapy for choledocholithiasis.
Procedure steps:
  1. Duodenoscope advanced to 2nd part of duodenum
  2. Ampulla of Vater cannulated with guide wire
  3. Cholangiogram performed to map stones and anatomy
  4. Endoscopic sphincterotomy (EST) - incision of the sphincter of Oddi
  5. Stone extraction using:
    • Balloon catheter (Fogarty-type) - sweeps stones
    • Dormia basket - captures and retrieves stones
    • For large stones: endoscopic balloon dilation (EBD) of papilla
  6. For large/impacted stones:
    • Mechanical lithotripsy (wire basket crushing)
    • Laser lithotripsy (holmium laser)
    • Electrohydraulic lithotripsy (EHL)
  7. Final occlusion cholangiogram to confirm clearance
Success rate: ~90%; retention rate increases with stone size >15 mm
Complications of ERCP:
ComplicationFrequency
Post-ERCP pancreatitis3-5% (most common)
Cholangitis1-3%
Bleeding from sphincterotomy1-2%
Duodenal perforation<1%
Biliary perforation<1%
(Mulholland & Greenfield's Surgery 7e; Fischer's Mastery of Surgery 8e)

B. Surgical Approach - Common Bile Duct Exploration (CBDE)

When preferred over ERCP:
  • Large, impacted stones
  • Multiple failed endoscopic attempts
  • Anatomy precluding endoscopy (e.g., previous Roux-en-Y gastric bypass, Billroth II)
  • Intermediate-risk patient with IOC confirming stones (single-stage approach)

CBD Exploration Techniques Compared

TranscysticTranscholedochal (Choledochotomy)
IndicationSmall stones (≤1 cm), CBD <1 cmLarge stones (>1 cm), CBD >1 cm
Success80-90%83-96%
Bile leak1%14%
Pancreatitis0.5%7.3%
ReoperationLow7.3%
MortalityLow1%
Choledochotomy closure:
  • Primary closure - if all stones removed and CBD clear
  • T-tube drainage - if residual stone risk, CBD edema, or concern for retained stones (T-tube cholangiogram performed at day 7-10 post-op)
(Mulholland & Greenfield's Surgery 7e)

C. Percutaneous Approach

Used when ERCP is not feasible:
  1. Rendezvous procedure: percutaneous transhepatic guide wire passed through bile ducts into duodenum → endoscopist uses this wire for ERCP. Useful in Billroth II anatomy or large duodenal diverticulum.
  2. Complete percutaneous approach: Transhepatic fistula created, matured for 7-8 days, then used for stone retrieval (multiple sessions required).

D. Laparoscopic-Assisted ERCP

For post-Roux-en-Y gastric bypass patients: laparoscopic gastrostomy in gastric remnant → trocar placed → endoscope passed through trocar to reach ampulla and perform ERCP.

E. Biliary Bypass Surgery (Rare)

For recurrent stones or distal biliary stricture (after excluding malignancy):
  • Choledochoduodenostomy (CDD) - simpler, allows future endoscopic access
  • Roux-en-Y hepaticojejunostomy - when duodenum cannot be mobilized; limits future endoscopic access

10. ERCP vs CBD EXPLORATION - DECISION TABLE

ScenarioPreferred Approach
High-risk group - cholangitis, severe gallstone pancreatitisERCP before cholecystectomy
Intermediate-risk with IOC confirming stones (intraop)Laparoscopic CBDE (single stage)
Failed endoscopy, large impacted stonesOpen or laparoscopic CBDE
Altered anatomy (gastric bypass, Billroth II)Percutaneous rendezvous or LA-ERCP
Post-cholecystectomy discovery of stonesERCP (6 weeks after cholecystectomy)

11. CHOLECYSTECTOMY TIMING

  • After ERCP clears the CBD: laparoscopic cholecystectomy same admission or within 2 weeks (to prevent recurrent events, since gallbladder remains the source of secondary stones)
  • Single-stage laparoscopic cholecystectomy + CBDE = equivalent duct clearance, equivalent morbidity, but shorter hospital stay compared to two-stage ERCP then cholecystectomy

12. PERIOPERATIVE MANAGEMENT OF JAUNDICED PATIENT (Key Surgical Points)

IssueManagement
Infection risk (infected bile >95% of cases)Prophylactic antibiotics
Renal failure risk (hepatorenal syndrome)Aggressive IV fluids perioperatively, 10% Mannitol infusion intraoperatively, urinary catheter with urine output >40 mL/hr target
CoagulopathyCheck PT/INR, give IM Vitamin K preoperatively
HypoalbuminemiaCorrect nutritional deficits
Wound healingMass closure with non-absorbable sutures in prolonged jaundice
ElectrolytesAvoid excess saline (salt retention tendency); correct fluid deficits
(Pye's Surgical Handicraft 22e)

13. VISUAL SUMMARY OF ERCP PROCEDURE

Multi-modal ERCP image showing CT stone, endoscopic cannulation, sphincterotomy, Dormia basket extraction, and final clearance cholangiogram
ERCP sequence: (a) CT showing hyperdense stone in distal CBD; (b,d,f) Endoscopic views - cannulation, sphincterotomy, basket extraction; (c,e,g) Fluoroscopy confirming clearance
ERCP stone extraction with balloon catheter showing dark green bile-stained choledocholiths

14. QUICK DIFFERENTIALS - CAUSES OF OBSTRUCTIVE JAUNDICE

BenignMalignant
Choledocholithiasis (most common benign)Cancer of head of pancreas (most common malignant)
Mirizzi syndromeCholangiocarcinoma (Klatskin tumor - hilar)
Benign biliary strictureAmpullary carcinoma
Choledochal cystGallbladder cancer
Primary sclerosing cholangitisDuodenal carcinoma
Sphincter of Oddi dysfunctionMetastatic nodes at porta hepatis

15. KEY NUMBERS TO REMEMBER

ValueSignificance
Jaundice visible atBilirubin >2.5-3 mg/dL
Normal CBD diameter≤6 mm (≤8 mm post-cholecystectomy)
CBD dilation on USS>6 mm = "strong" predictor of stone
Bilirubin "Very Strong" predictor>4 mg/dL
Bilirubin "Strong" predictor1.8-4 mg/dL
CBD stones in symptomatic gallstone disease10-15%
CBD stones in cholecystitis patients10-20%
Spontaneous stone passage (low-risk)~30%
ERCP success rate~90%
MRCP sensitivity81-100%
MRCP specificity92-100%
Transcystic CBDE success80-90%
Choledochotomy success83-96%

Sources

  • Mulholland and Greenfield's Surgery: Scientific Principles and Practice, 7e - Chapter 61
  • Fischer's Mastery of Surgery, 8e - Biliary Surgery
  • Schwartz's Principles of Surgery, 11e - Jaundice chapter
  • Guyton and Hall Textbook of Medical Physiology - Bilirubin physiology
  • Harper's Illustrated Biochemistry, 32nd ed - Bilirubin metabolism tables
  • Pye's Surgical Handicraft, 22e - Perioperative jaundice management
  • Gray's Anatomy for Students - Biliary anatomy
Recent Evidence Note (PubMed 2024-2025): A systematic review (PMID 38555329, Dig Dis Sci 2024) confirmed comparable post-ERCP adverse event rates between symptomatic and asymptomatic choledocholithiasis - supporting active treatment even in asymptomatic cases. A 2025 Bayesian network meta-analysis (PMID 40905968) on balloon dilation duration provides updated guidance on EST + EBD timing for stone extraction.
This is a shared conversation. Sign in to Orris to start your own chat.